Tag: placebo-given

BRUSSELS (Reuters) – Belgian biotech group Galapagos said its experimental drug to treat bowel disease ulcerative colitis had failed to prove its efficacy in a medical trial and it would discontinue the program for that disease. While the drug GLPG1205 was well tolerated, Galapagos said it did not perform better than the placebo given to…